The Ontario Medical Association (OMA) and Primary Care Collaborative have called for $37.5 million in immediate funding, as well as $75 million annually for 10 years, to help primary care providers treat patients with depression, anxiety, and addiction. The recommendation is part of a four-point plan to strengthen mental health and […]
Read More
La decisión de no vacunarse contra la COVID-19 por ya haber pasado la enfermedad y confiar en la inmunidad adquirida de forma natural es una mala elección, al menos antes de que la variante ómicron fuese la dominante. Esta es la principal conclusión de un estudio liderado por investigadores del […]
Read More
More than 2 years into the coronavirus disease 2019 (Covid-19) pandemic, the global population carries heterogeneous immune histories derived from various exposures to infection, viral variants, and vaccination.1 Evidence at the level of binding and neutralizing antibodies and B-cell and T-cell immunity suggests that a history of infection with severe acute […]
Read More
Unsupervised SARS-CoV-2 rapid antigen testing with three commercial kits had 70% to 81% sensitivity during the period when Omicron emerged and became predominant in the Netherlands. Rapid antigen testing for COVID-19 has largely replaced RT-PCR testing in the ambulatory setting, but accuracy data are limited. Dutch investigators performed a prospective […]
Read More
A potentially fatal strain of flu currently in circulation worldwide could be more of a threat to public health than COVID this winter, a senior government health adviser has warned. Dr Susan Hopkins, chief medical adviser at UK Health Security Agency (UKHSA) warned that COVID will still present a major challenge for […]
Read More
FDA added important information to the authorized Fact Sheets for Evusheld (tixagevimab co-packaged with cilgavimab) to inform health care providers and individuals receiving Evusheld of the increased risk for developing COVID-19 when exposed to variants of SARS-CoV-2 that are not neutralized by Evusheld. Detailed neutralization data can be found in […]
Read More
“No hemos llegado al final de la pandemia: aún estamos en el túnel y hay muchos obstáculos que pueden hacernos tropezar: brechas de vacunación, bajos índices de pruebas y secuenciación, así como falta de acceso a antivirales”, advirtió el lunes 26 de septiembre el director general de la Organización Mundial […]
Read More
If you have heart disease, or have survived a heart attack or stroke, you know it can be challenging – even during normal times. COVID-19 has added another layer of worry, leaving many people with heart disease and other conditions on even higher alert than usual to stay healthy. Experts […]
Read More
Despite significant progress over the last few decades, meningitis remains a much-feared disease worldwide with a high case fatality rate and a propensity to cause epidemics that present a major challenge for health systems, economies and society. Meningitis caused an estimated 250 000 deaths in 2019, leaving one in five […]
Read More
El pasado domingo 18 de septiembre, el presidente de Estados Unidos, Joe Biden, declaró como terminada la pandemia de COVID-19 en Estados Unidos; sin embargo, una nueva subvariante del virus que causa la enfermedad podría dar un duro revés a las declaraciones del mandatario y al curso mismo de la pandemia. Hablamos de […]
Read More